Glenmark inks deal with SaNOtize for COVID treatment spray in India, other Asian markets

PTIUpdated: Monday, August 02, 2021, 11:15 AM IST
article-image
Glenmark | Photo credit: Twitter

Drug firm Glenmark Pharmaceuticals on Monday said it has signed an agreement with Canadia's biotech firm SaNOtize Research and Development Corp to commercialise its Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

Glenmark Pharmaceuticals and SaNOtize Research and Development Corp announced an exclusive long term strategic partnership to manufacture, market and distribute its breakthrough Nitric Oxide Nasal Spray (NONS)in Asian markets including India, Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Sri Lanka, Timor Leste and Vietnam, Glenmark said in a regulatory filing.

Glenmark said in early July 2021, the company presented a proposal to the subject expert committee of CDSCO for emergency approval for import and marketing of the nasal spray.

"The committee has recommended a phase III clinical trial to be conducted in Indian patients in the weeks to follow. The phase III clinical trial for NONS is expected to be completed, followed by commercial launch under the brand name FabiSpray in India, by fourth quarter of the calendar year 2021," the company added.

“This partnership with SaNOtize closely aligns with Glenmark's focused approach against COVID-19 and will help reduce the burden of the pandemic in the region.” said Glenn Saldanha, Chairman and MD, Glenmark Pharmaceuticals.

SaNOtize developed and patented a Nitric Oxide Releasing Solution platform technology (NORSTM) to treat and prevent microbial infections in 2017. Glenmark's partnership with SaNOtize will bring in much needed therapeutic relief to patients in India and Asia.

(If you have a story in and around Mumbai, you have our ears, be a citizen journalist and send us your story here. )

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Indian traders accuse Samsung of anti-competitive practices, write to CCI

Indian traders accuse Samsung of anti-competitive practices, write to CCI

India's CAG calls AI game changer for public audit

India's CAG calls AI game changer for public audit

Tata, MG dragged back as EV sales drop by 10% in India

Tata, MG dragged back as EV sales drop by 10% in India

GVK Vice Chairman denies Rahul Gandhi's claims about pressure to sell Mumbai airport to Adani

GVK Vice Chairman denies Rahul Gandhi's claims about pressure to sell Mumbai airport to Adani

Axis Bank allots 2,80,256 shares as stock options for employees

Axis Bank allots 2,80,256 shares as stock options for employees